FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LOXAPINE submitted by Actavis Pharma, Inc. (ANDA072062).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)